Status:
COMPLETED
Validation of the BREATHE Asthma Intervention Trial
Lead Sponsor:
Columbia University
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal of this study to preliminarily validate a novel intervention delivered by primary care providers (PCPs) to their Black adult patients with uncontrolled asthma in federally qualified h...
Detailed Description
Nearly every asthma related hospitalization and death could be prevented with appropriate self-management that achieves and maintains disease control. However, as many as 64% of adults have uncontroll...
Eligibility Criteria
Inclusion
- PROVIDER RECRUITMENT
- PCPs (MDs and Nurse Practitioners (NPs)/Physician Assistants (PAs)) working in family, primary or internal medicine care services
- Who have at least 40 adult patients with persistent asthma (defined as having been prescribed ICS) on their patient panel
Exclusion
- PCPs whose primary focus is outside of adult health services (family, primary or internal medicine), such as behavioral health, pediatrics and Obstetrics and Gynaecology (OB-GYN)
- PATIENT RECRUITMENT
- Inclusion Criteria:
- Patients must be
- adults (\> or = 18 years of age) who self-report race as Black or African American
- with PCP-diagnosed persistent asthma
- prescribed ICS
- receiving asthma care at participating FQHCs
- who have uncontrolled asthma
- have erroneous personal health and/or negative ICS beliefs
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03300752
Start Date
October 1 2017
End Date
May 30 2019
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032